Literature DB >> 2495329

B cell response pathways regulated by IL-5 and IL-2. Secretory microH chain-mRNA and J chain mRNA expression are separately controlled events.

K Matsui1, K Nakanishi, D I Cohen, T Hada, J Furuyama, T Hamaoka, K Higashino.   

Abstract

We have examined the effect of IL-5 and/or IL-2 on the expression of the secretory form of microH chain (microsecond) and J chain mRNA in a homogeneous neoplastic B cell clone, in which proliferation, IL-2R up-regulation and entry into the IgM secretory state are separately controlled events. The IL-5 signal triggers a partial induction of CL-3 cells into the IgM secretory state, characterized by a striking increase of microsecond mRNA expression and an increase in the ratio of the secretory to membrane forms of microH chain mRNA, with a modest increase of J chain mRNA. In contrast, amplification of J chain mRNA is accomplished by the late-acting B cell differentiation stimulus, IL-2, acting on IL-5-pretreated CL-3 cells or acting simultaneously with IL-5 on CL-3 cells. Such dually stimulated cells now are fully induced into IgM secreting cells. These results define the relative roles of IL-5 and IL-2 in B cell differentiation by showing important regulatory effects at the mRNA level. In addition, these results substantiate that appearance of mRNA for J chain, a molecule key to the formation of pentameric IgM, is a limiting factor for high level IgM secretion. The separate control of microsecond and J chain mRNA found in CL-3 cells stimulated with IL-5 and IL-2 elucidates a molecular mechanism by which these two lymphokines synergize in the development of CL-3 cells into IgM secreting cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2495329

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Polymer IgM assembly and secretion in lymphoid and nonlymphoid cell lines: evidence that J chain is required for pentamer IgM synthesis.

Authors:  M J Niles; L Matsuuchi; M E Koshland
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

2.  A promoter element that exerts positive and negative control of the interleukin 2-responsive J-chain gene.

Authors:  R D Lansford; H J McFadden; S T Siu; J S Cox; G M Cann; M E Koshland
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

3.  Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase.

Authors:  J Yu; C Angelin-Duclos; J Greenwood; J Liao; K Calame
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

4.  Interleukin 2- and interleukin 5-induced changes in the binding of regulatory factors to the J-chain gene promoter.

Authors:  H J McFadden; M E Koshland
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

5.  J chain synthesis and secretion of hexameric IgM is differentially regulated by lipopolysaccharide and interleukin 5.

Authors:  T D Randall; R M Parkhouse; R B Corley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

6.  In vivo effects of anticytokine antibodies on isotype restriction in Mesocestoides corti-infected BALB/c mice.

Authors:  D M Estes; J M Teale
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

7.  Interleukin 5 (IL-5) provides a signal that is required in addition to IL-4 for isotype switching to immunoglobulin (Ig) G1 and IgE.

Authors:  J M Purkerson; P C Isakson
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

8.  Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6.

Authors:  R Reljic; S D Wagner; L J Peakman; D T Fearon
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

9.  Differential effect of B lymphocyte-induced maturation protein (Blimp-1) expression on cell fate during B cell development.

Authors:  E J Messika; P S Lu; Y J Sung; T Yao; J T Chi; Y H Chien; M M Davis
Journal:  J Exp Med       Date:  1998-08-03       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.